PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21392639-3 2011 Atorvastatin, omeprazole, and several other drugs have been shown in pharmacodynamic studies to competitively inhibit CYP activation of clopidogrel, reducing clopidogrel responsiveness. Atorvastatin 0-12 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 118-121 23903277-6 2013 Lipophilic statins, such as atorvastatin, are predominantly metabolized by CYP3A4 and may interfere with CYP activation of clopidogrel, contrary to what happens with hydrophilic statins, such as rosuvastin or pravastatin. Atorvastatin 28-40 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 75-78 10575059-5 1999 The lipophilic drugs lovastatin, simvastatin, atorvastatin, cerivastatin and fluvastatin are metabolized via the cytochrome P450 (CYP450) system in the liver and the gut, making them subject to potential interactions with concomitantly administered drugs that are competing for metabolism via this system. Atorvastatin 46-58 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 113-128 11038166-1 2000 In an in vitro study, we compared the cytochrome P450 (CYP)-dependent metabolism and drug interactions of the acid and lactone forms of the 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitor atorvastatin. Atorvastatin 197-209 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 38-53 11038166-1 2000 In an in vitro study, we compared the cytochrome P450 (CYP)-dependent metabolism and drug interactions of the acid and lactone forms of the 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitor atorvastatin. Atorvastatin 197-209 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 55-58 11122720-3 2000 Despite an excellent safety record, CYP 3A4 statins (lovastatin, simvastatin, atorvastatin) taken concomitantly with a potent CYP 3A4 inhibitor may increase the risk for adverse events (myopathy, rhabdomyolysis). Atorvastatin 78-90 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 36-39 11122720-3 2000 Despite an excellent safety record, CYP 3A4 statins (lovastatin, simvastatin, atorvastatin) taken concomitantly with a potent CYP 3A4 inhibitor may increase the risk for adverse events (myopathy, rhabdomyolysis). Atorvastatin 78-90 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 126-129 11475198-4 2001 RESULT: More than 50% of the overall CYP metabolism is mediated through the isoenzyme CYP3A4, which is the main elimination route of simvastatin, lovastatin and atorvastatin. Atorvastatin 161-173 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 37-40 10575059-5 1999 The lipophilic drugs lovastatin, simvastatin, atorvastatin, cerivastatin and fluvastatin are metabolized via the cytochrome P450 (CYP450) system in the liver and the gut, making them subject to potential interactions with concomitantly administered drugs that are competing for metabolism via this system. Atorvastatin 46-58 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 130-136